Skip to Main Content
  • McGraw Hill Medical
  • McGraw Hill Medical
    • Umbrella Logo Dropdown McGraw Hill Medical Home
    • Explorar m?s sitios
      AccessAnesthesiology
      AccessAPN
      AccessBiomedical Science
      AccessCardiology
      AccessDermatologyDxRx
      AccessEmergency Medicine
      AccessHemOnc
      AccessMedicina
      AccessMedicine
      AccessNeurology
      AccessObGyn
      AccessPediatrics
      AccessPharmacy
      AccessPhysiotherapy
      AccessSurgery
      Case Files Collection
      Clinical Sports Medicine Collection
      F.A. Davis AT Collection
      F.A. Davis PT Collection
      JAMAevidence
      Murtagh Collection
      OMMBID
      Pharmacotherapy Principles & Practice
  • Soporte técnico
    • Recursos para usuarios
    • ¿Quiénes somos?
    • Contáctenos
    • Enviar retroalimentación
  • Suscripciones
Iniciar sesión Sign In

Inicio de sesión MyAccess

Crear un perfil gratuito MyAccess
¿Olvidó su contraseña?
¿Olvidó su nombre de usuario?

Acerca de MyAccess

Si su institución se suscribe a este recurso y usted no tiene un perfil MyAccess, por favor póngase en contacto con el departamento de referencia de su biblioteca para obtener información sobre cómo acceder a este recurso desde fuera del campus.

Leer más
Inicie sesión mediante OpenAthens
Inicie sesión mediante Shibboleth
AccessMedicina home page Home
Navigation Menu Search Menu
  • Libros
  • Referencia rápida
    • Diagnosaurus®
    • Pruebas de diagnóstico
    • Guías
    • Calculadoras
    • 2 Minute Medicine®
    • Acrónimos
  • Fármacos
    • Monografías de fármacos
    • Interacción de fármacos
  • Multimedia
    • Animaciones 3D
    • Anatomía 3D - Módulos
    • Anatomía 3D - Desafío de anatomía
    • COVID-19
    • Harrison Podclass
    • Vídeos por aparatos y sistemas
    • Lecciones de farmacología
    • Harrison Animaciones de fisiopatología
    • Medicina de urgencias
  • Infografías
  • Casos
    • Casos
    • Desequilibrios hidroelectrolíticos/trastornos
    • Fisiopatología
    • Harrison Casos. Desafío visual
  • Autoevaluación
    • Por Recurso
    • Flashcards
  • Educación del paciente
     
    Acerca de búsqueda
    Enable Autosuggest
    ¡Bienvenido!

    Ha creado correctamente un Perfil de MyAccess para
    alertsuccessName.

    Las características de MyAccess incluyen:
    • Acceso remoto
    • Favoritos
    • Guardar figuras en PowerPoint
    • Descargar cuadros como archivos PDF
    Ir al Panel de control  Cerrar
    Inicio > 2 Minute Medicine® > Dermatology >
    Book cover
    Editors and Contributors

    The Management of Lesions to Exclude Melanoma schema may be a clinically useful and accurate classification system for melanocytic lesions

    by Jake Engel, Michael Pratte
    +

    Originally published by 2 Minute Medicine® (view original article). Reused on AccessMedicine with permission.

    +

    1. Pathologists demonstrated high accuracy in diagnosing melanocytic lesions using the Management of Lesions to Exclude Melanoma (MOLEM) classification system on high-risk patients

    +

    2. Furthermore, the numerical classification of the MOLEM system may be more easily integrated into artificial intelligence algorithms compared to other qualitative and language-based schemas.

    +

    Evidence Rating Level: 2 (Good)

    Study Rundown:

    +
    +

    Melanoma is diagnosed with a morphological assessment of a biopsied lesion. There appears to be a discordance between pathologists in diagnosing melanoma from other lesions called “borderline lesions.” The Management of Lesions to Exclude Melanoma (MOLEM) schema is separated into five classes (I-V) and used to differentiate melanocytic from nonmelanocytic lesions. This classification system may be utilized to improve diagnoses and potentially used in the future as algorithms to train artificial intelligence. This cohort study investigated the accuracy and confidence of pathologists in diagnosing melanoma in high-risk patients using the MOLEM classification system. Study patients were from a primary care skin clinic in New South Wales, Australia, from April 2019 until December 2019. Lesions were reviewed by a minimum of five and up to nine independent pathologists; they reported their MOLEM class and confidence rating (1 [most] – 5 [least]) in their diagnoses. The reference standard was defined as the most frequent MOLEM class for each case. The outcomes were interrater agreement and diagnostic confidence of excised lesions by the pathologists. One hundred ninety-seven high-risk patients for suspected melanoma were included in the study, with a total of 1516 histological diagnoses from 217 lesions. The overall quadratic weighted interrater agreement for MOLEM class ratings was 91.3% (Gwet AC1 coefficient: 0.76 [95% CI: 0.72-0.81]) with the lowest agreement in class II of 82.1% (Gwet AC1 coefficient: 0.55 [95% CI: 0.44-0.66]) and the highest agreement in class V of 96.6% (Gwet AC1 coefficient: 0.94 [95%CI: 0.88-1.00]). The overall quadratic weighted interrater agreement for confidence ratings was 95.2% (Gwet AC1 coefficient: 0.92 [95% CI: 0.90-0.94]), with the lowest agreement in class II of 93.5% (Gwet AC1 coefficient: 0.85 [95% CI: 0.79-0.91]) and the highest agreement in class V of 97.5% (Gwet AC1 coefficient: 0.97 [95% CI: 0.93-1.00]). This study demonstrated that the MOLEM classification is clinically useful with a high level of agreement between pathologists; in cases that were more in doubt, pathologists were aware of the difficulty and admitted to diagnosing with less confidence. Notably, it is important to consider that the methodology was limited by selection bias based on the included cohort and by observation bias as the pathologists’ subjective criteria and cognitive biases may have played a role in their diagnoses.

    +

    Click to read the study in JAMA Network Open

    +

    Relevant Reading: The MPATH-Dx reporting schema for melanocytic proliferations and melanoma

    +

    ©2021 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

    Pop-up div Successfully Displayed

    This div only appears when the trigger link is hovered over. Otherwise it is hidden from view.

    Please Wait

    2MM Topics
    Chronic Disease
    Dermatology

    AccessMedicina

    • Libros
    • Referencia rápida
    • Diagnosaurus®
    • Pruebas de diagnóstico
    • Guías
    • Calculadoras
    • 2 Minute Medicine®
    • Acrónimos
    • Fármacos
    • Monografías de fármacos
    • Interacción de fármacos
    • Multimedia
    • Animaciones 3D
    • Anatomía 3D - Módulos
    • Anatomía 3D - Desafío de anatomía
    • COVID-19
    • Harrison Podclass
    • Vídeos por aparatos y sistemas
    • Lecciones de farmacología
    • Harrison Animaciones de fisiopatología
    • Medicina de urgencias
    • Infografías
    • Casos
    • Casos
    • Desequilibrios hidroelectrolíticos/trastornos
    • Fisiopatología
    • Harrison Casos. Desafío visual
    • Autoevaluación
    • Por Recurso
    • Flashcards
    • Educación del paciente
    • Acerca de

    McGraw Hill Medical

    • Sites
    • AccessAnesthesiology
    • AccessAPN
    • AccessBiomedical Science
    • AccessCardiology
    • AccessDermatologyDxRx
    • AccessEmergency Medicine
    • AccessHemOnc
    • AccessMedicina
    • AccessMedicine
    • AccessNeurology
    • AccessObGyn
    • AccessPediatrics
    • AccessPharmacy
    • AccessPhysiotherapy
    • AccessSurgery
    • Case Files Collection
    • Clinical Sports Medicine Collection
    • F.A. Davis AT Collection
    • F.A. Davis PT Collection
    • JAMAevidence
    • Murtagh Collection
    • OMMBID
    • Pharmacotherapy Principles & Practice
    • Soporte técnico
    • Recursos para usarios
    • ¿Quiénes somos?
    • Contáctenos
    • Enviar retroalimentación
    • Suscripciones
    • Suscripciones Institucionales
    • Suscripciones individuales
    McGraw Hill

    Copyright © McGraw Hill
    Todos los derechos reservados.
    Su dirección IP es 3.236.70.233
    Términos de uso   •  Aviso de privacidad   •  Anuncio   •  Soporte de Navegador

    Silverchair
    Arriba
    >
    Este sitio usa cookies. Al continuar navegando en este sitio, usted acepta nuestro uso de cookies. Más información Cerrar